Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00539539 · ClinicalTrials.gov registry record · Phase 2
Automated Real-time Feedback on CPR Study
A Phase 2 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,586
- Enrollment target
NCT00539539: Completed Phase 2 study, sponsored by University of Washington.
NCT00539539 is a Phase 2 study that has completed, run by University of Washington. The registered enrollment target is 1,586 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1092% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00539539, a Phase 2 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,586 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether or not real-time feedback on CPR process variables will increase rates of restoration of spontaneous circulation during prehospital resuscitation and upon arrival at the receiving emergency room as well as increase rates of survival to hospital discharge.
Primary Outcome
Return of spontaneous circulation (ROSC)
Interventions
- OTHER Laerdal Q-CPR /technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,586 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
What the finished NCT00539539 record still lists
NCT00539539 is an interventional study that assigns participants to a tested intervention. Its 1,586 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1092% higher).
The record links to 0 conditions, and to 1 intervention - of which Laerdal Q-CPR /technology is the first listed.
NCT00539539 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00539539 about?
NCT00539539 is a clinical study titled "Automated Real-time Feedback on CPR Study". The purpose of this study is to evaluate whether or not real-time feedback on CPR process variables will increase rates of restoration of spontaneous circulation during prehospital resuscitation and upon arrival at the receiving emergency room as well as increase rates of survival to hospital discha...
What is the current status of trial NCT00539539?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,586 participants. The study started on 2007-02. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00539539?
The interventions under investigation include: Laerdal Q-CPR /technology (OTHER).
Who is sponsoring clinical trial NCT00539539?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00539539's enrollment target sits among peer trials
1,586 11th of 2000 higher than 1,990 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05552222 · 1,590 participants · Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- NCT06632457 · 1,590 participants · Phase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
- NCT05243797 · 1,594 participants · Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia